Vanguard Portfolio Management
WHWK

Vanguard Portfolio Management’s Whitehawk Therapeutics WHWK Stock Holding History

Vanguard Portfolio Management’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Buy
+219,217
New +$912K ﹤0.01% 2958

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management's WHWK Position: Q2 2026 in Review

Vanguard Portfolio Management opened a new position in Whitehawk Therapeutics (WHWK) in Q2 2026: 219,217 shares worth $1M. The stake represents ﹤0.01% of the portfolio and ranks #2958 among its holdings.

78 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Vanguard Portfolio Management held 219,217 shares of Whitehawk Therapeutics worth $1M as of Q2 2026.
  • Whitehawk Therapeutics was a new Vanguard Portfolio Management position in Q2 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2958 holding.
  • 78 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.